Sigma Planning Corp Regeneron Pharmaceuticals, Inc. Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Sigma Planning Corp holds 409 shares of REGN stock, worth $293,122. This represents 0.01% of its overall portfolio holdings.

Number of Shares

409

Previous 393 4.07%

Holding current value

$293,122

Previous $413,000 3.87%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$1024.09 - $1201.76 $16,385 - $19,228	16 Added 4.07%	409 $429,000
Q2 2024 Aug 05, 2024	BUY	$883.2 - $1071.19 $22,080 - $26,779	25 Added 6.79%	393 $413,000
Q1 2024 May 01, 2024	BUY	$902.69 - $993.35 $332,189 - $365,552	368 New	368 $354,000
Q3 2023 Nov 06, 2023	SELL	$692.45 - $844.37 $48,471 - $59,105	-70 Reduced 15.38%	385 $316,000
Q2 2023 Aug 01, 2023	SELL	$700.03 - $830.35 $22,400 - $26,571	-32 Reduced 6.57%	455 $326,000
Q1 2023 May 05, 2023	SELL	$680.49 - $826.97 $100,712 - $122,391	-148 Reduced 23.31%	487 $400,000
Q4 2022 Jan 24, 2023	BUY	$705.89 - $766.39 $100,236 - $108,827	142 Added 28.8%	635 $0
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $30,420 - $38,388	-53 Reduced 9.71%	493 $340,000
Q2 2022 Aug 11, 2022	SELL	$548.35 - $738.84 $4,386 - $5,910	-8 Reduced 1.44%	546 $323,000
Q1 2022 Apr 20, 2022	SELL	$595.12 - $698.43 $57,131 - $67,049	-96 Reduced 14.77%	554 $387,000
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $36,413 - $44,954	67 Added 11.49%	650 $410,000
Q3 2021 Oct 28, 2021	SELL	$574.03 - $680.96 $432,244 - $512,762	-753 Reduced 56.36%	583 $353,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $62,882 - $74,285	-133 Reduced 9.05%	1,336 $746,000
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $122,404 - $150,206	274 Added 22.93%	1,469 $695,000
Q4 2020 Feb 09, 2021	SELL	$478.3 - $607.98 $66,005 - $83,901	-138 Reduced 10.35%	1,195 $577,000
Q3 2020 Nov 03, 2020	SELL	$544.75 - $658.21 $2.01 Million - $2.43 Million	-3,689 Reduced 73.46%	1,333 $746,000
Q2 2020 Jul 31, 2020	BUY	$493.32 - $643.92 $2.06 Million - $2.69 Million	4,173 Added 491.52%	5,022 $3.13 Million
Q1 2020 May 01, 2020	SELL	$336.18 - $494.43 $176,494 - $259,575	-525 Reduced 38.21%	849 $415,000
Q4 2019 Feb 03, 2020	BUY	$274.13 - $376.51 $23,301 - $32,003	85 Added 6.59%	1,374 $516,000
Q3 2019 Nov 01, 2019	BUY	$273.46 - $318.39 $69,458 - $80,871	254 Added 24.54%	1,289 $358,000
Q2 2019 Aug 01, 2019	BUY	$299.6 - $414.82 $310,086 - $429,338	1,035 New	1,035 $324,000
Q4 2018 Jan 31, 2019	SELL	$335.82 - $403.04 $262,275 - $314,774	-781 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $27,388 - $31,863	-78 Reduced 9.08%	781 $316,000
Q2 2018 Aug 02, 2018	BUY	$284.6 - $344.99 $75,419 - $91,422	265 Added 44.61%	859 $296,000
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $187,597 - $233,905	594 New	594 $205,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Regeneron Pharmaceuticals, Inc. Transaction History